retatrutide phase 3 results are in. TRIUMPH-1 topline: 28.3% average weight loss at 80 weeks, 30.3% at 104 weeks in participants with BMI 35 or higher. That averages 85 lbs. No pharmaceutical Phase III retatrutide study demonstrates

As a rough guide, this equates to approximately 1219 g of fat per main meal, depending on your individual daily calorie target

When GLP-1 receptors are activated, several effects occur: Wegovy can lead to significant weight loss when used alongside diet and physical activity

Hong Kong: Oxford University Press

Hormone replacement therapies, including testosterone, bioidentical hormones, and progesterone, address symptoms such as low energy, reduced libido, or menopausal discomfort, helping both men and women feel more vibrant

Luzzi V, Mazur M, Guaragna M, et al

5-8 weeks : Your healthcare provider will increase the dosage to 2 mg once weekly